Bladder Cancer Care: AHN is rolling out Inlexzo (formerly TAR-200), an indwelling gemcitabine system designed to extend local drug exposure for BCG-unresponsive NMIBC while avoiding systemic toxicity. Pediatric Oncology: A 5-year ELIANA analysis shows durable, manageable long-term results for tisagenlecleucel in pediatric/young adult B-ALL. CAR T Decision-Making: Experts discuss why early referral and careful patient selection matter in multiple myeloma, and how sequencing CAR T before bispecifics may improve outcomes. End-of-Life Access: Vancouver Coastal Health is reopening Cottage Hospice with upgrades and a new operating partnership to meet ongoing demand for palliative care. Pediatric Allergy Screening: Symptom-based screening in children with asthma found unexpectedly high eosinophilic esophagitis rates, supporting earlier evaluation. Healthcare Workforce Burnout: Cardiac CT specialist burnout is worsening, with calls for structural fixes beyond individual resilience. Pharma Deals & Delivery: Tarsus will acquire Alkeus for $450M to advance a Stargardt therapy; Amazon Pharmacy begins $50/month GLP-1 delivery for eligible Medicare patients. Public Health & Safety: A study flags high severe-disease risk among hospitalized children with acute respiratory tract infections, especially after transfers. Opioid Misuse Economics: A University of Utah evaluation finds mindfulness-based MORE could be highly cost-effective for opioid misuse and chronic pain.